MEXC to Serve as Major Sponsor at Solana Summit APAC 2025, Reinforcing Commitment to SOL Ecosystem Growth
VICTORIA, Seychelles, June 3, 2025 /PRNewswire/ --Â MEXC, a leading global cryptocurrency exchange,…
OHI Group S.A. Announces Consent Solicitation Relating to its U.S.$400,000,000 13.000% Senior Secured Amortizing Notes due 2029 Regulation S Notes: CUSIP L7S61M AB5, ISIN USL7S61MAB59 Rule 144A Notes: CUSIP 67712M AB5, ISIN US67712MAB54 (the “Notes”)
Executive Summary — As previously announced, OHI Group S.A. (the "Issuer") is preparing…
HOTEL101 PROGRESSES TOWARDS NASDAQ LISTING
U.S. SEC DECLARES FORM F-4 SEC REGISTRATION EFFECTIVE SINGAPORE, June 2, 2025…
NYSE Content Advisory: Pre-Market update + U.S. – China trade tensions escalate
NEW YORK, June 2, 2025 /PRNewswire/ -- The New York Stock Exchange…
![Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]](https://i0.wp.com/ml-eu.globenewswire.com/media/NjEzMmQ4NzAtZTBkMS00ZDhhLTkyYjgtOGM3YzY1ZWM5M2U5LTEwMTQyODItMjAyNS0wNi0wMi1lbg==/tiny/Sandoz-International-GmbH.png?w=420&resize=420,280&ssl=1 "Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]")
Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]
Ad-hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA…
KBRA Comments on Amendment to Sunnovas Loan Guarantee Agreement with DOE
NEW YORK--(BUSINESS WIRE)--#creditratingagency--In an 8-K filing with the Securities and Exchange Commission…
